himm full correctionHims & Hers Health, Inc.BATS:HIMSApollo_21milNow that I have 2,000 shares of hims this wide is pretty wild but my conviction remains high. First off, the market kept using net earnings to value the company, bad idea. Since hims spends so much on ads and stock based compensation you need to use operating cash flow. If you use this number the company is growing at multiples per year. Next, the GLP story. First off hims was growing immensely without this sector, their weight loss program was growing steadily without GLP. Compounded GLP is the cherry on top, if they are allowed to keep making these it will be good for the company, but they do not need them to grow very quickly. Hims is currently in hair loss, skin care, anxiety, ED, and primary care (huge market). They are soon adding sleep, fertility, more diabetes, and cholesterol. With their recent acquisition to be able to do at home blood draws, the sky is the limit. My plan: My covered calls printed, and I bought commons and a LEAP call for 2027